Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

THERESA AB LAWRENCE FORD

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1619935624
CMS profile
299982
Location
LAWRENCEVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$6,459.12

190 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 190 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

THERESA AB LAWRENCE FORD

NPI 1619935624 · CMS profile ID 299982

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

LAWRENCEVILLE, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 190 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619935624?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
THERESA AB LAWRENCE FORD, NPI 1619935624, CMS profile ID 299982. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 190 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619935624?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). THERESA AB LAWRENCE FORD, NPI 1619935624, CMS profile ID 299982. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 190 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619935624?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
THERESA AB LAWRENCE FORD, NPI 1619935624, CMS profile ID 299982, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 190 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1619935624?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

190 matching records · $6,459.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 190 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 190.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $17.5006/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015535 CMS
Janssen Biotech, Inc. $15.3106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788490635 CMS
AbbVie Inc. $27.3506/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247351 CMS
AbbVie Inc. $1.1006/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247357 CMS
Novartis Pharmaceuticals Corporation $4.9906/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015531 CMS
Genentech USA, Inc. $20.0006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835984153 CMS
Alfasigma USA, Inc. $18.5906/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853050795 CMS
PFIZER INC. $15.1706/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832711867 CMS
GlaxoSmithKline, LLC. $14.7906/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802096333 CMS
Amgen Inc. $24.3306/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825830311 CMS
AstraZeneca Pharmaceuticals LP $24.6906/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834328029 CMS
Novartis Pharmaceuticals Corporation $3.2606/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015527 CMS
AbbVie Inc. $1.2906/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247339 CMS
AbbVie Inc. $16.3106/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247345 CMS
Amgen Inc. $18.1106/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825830339 CMS
AbbVie Inc. $24.4806/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247329 CMS
AbbVie Inc. $8.1806/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247335 CMS
UCB, Inc. $13.0605/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807359235 CMS
Novartis Pharmaceuticals Corporation $6.1805/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015523 CMS
AbbVie Inc. $18.3805/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247323 CMS
E.R. Squibb & Sons, L.L.C. $16.0905/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783466941 CMS
Novartis Pharmaceuticals Corporation $11.6405/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015519 CMS
AbbVie Inc. $23.8605/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247317 CMS
Horizon Therapeutics plc $15.1705/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797163857 CMS
AbbVie Inc. $22.1805/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247313 CMS
GlaxoSmithKline, LLC. $15.1205/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802536475 CMS
Novartis Pharmaceuticals Corporation $8.0605/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015515 CMS
Horizon Therapeutics plc $7.1205/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797163855 CMS
AbbVie Inc. $22.5005/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247307 CMS
Amgen Inc. $21.8605/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825830307 CMS
GlaxoSmithKline, LLC. $12.8305/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803033503 CMS
AstraZeneca Pharmaceuticals LP $16.7505/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834323949 CMS
Horizon Therapeutics plc $19.1305/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797163853 CMS
UCB, Inc. $17.6505/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807349009 CMS
Novartis Pharmaceuticals Corporation $6.5204/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015507 CMS
Novartis Pharmaceuticals Corporation $14.2204/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015503 CMS
AbbVie Inc. $23.3504/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247301 CMS
Novartis Pharmaceuticals Corporation $4.2604/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015499 CMS
E.R. Squibb & Sons, L.L.C. $19.2404/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783466935 CMS
Janssen Biotech, Inc. $11.6204/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788490633 CMS
Novartis Pharmaceuticals Corporation $4.7304/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015511 CMS
Novartis Pharmaceuticals Corporation $21.5204/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015495 CMS
AbbVie Inc. $2.7804/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247295 CMS
AbbVie Inc. $24.5004/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247289 CMS
Amgen Inc. $22.1404/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825830335 CMS
AbbVie Inc. $12.5904/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795247283 CMS
Novartis Pharmaceuticals Corporation $11.3804/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813015491 CMS
Lilly USA, LLC $17.0203/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818683999 CMS
GlaxoSmithKline, LLC. $14.6903/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802336735 CMS
Mallinckrodt Hospital Products Inc. $27.9203/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845365627 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $314,654.14 550
PY2020 $37,999.57 166
PY2021 $6,459.12 190
PY2022 $33,700.09 211
PY2023 $12,198.84 198
PY2024 $3,147.86 139
PY2025 $2,074.36 27

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $138,028.32 9
PY2024 Principal investigator $416,363.97 20
PY2023 Principal investigator $255,094.14 12
PY2022 Recipient $3.00 1
PY2022 Principal investigator $162,526.68 16
PY2021 Principal investigator $321,539.19 32
PY2020 Recipient $1,034.60 3
PY2020 Principal investigator $516,037.97 50
PY2019 Recipient $3,000.69 1
PY2019 Principal investigator $674,418.56 61

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,658.35 12/24/2025 Non-covered Recipient Entity
North Georgia Rheumatology Group
Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus No dispute reported 06/30/2026 1235995301
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $18.55 11/20/2025 Non-covered Recipient Entity
North Georgia Rheumatology Group, PC
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjgren's Syndrome (POETYK SjS-1) No dispute reported 06/30/2026 1235995299
Principal investigator 1 Novartis Pharmaceuticals Corporation $9,922.00 09/04/2025 Non-covered Recipient Entity
NORTH GEORGIA RHEUMATOLOGY GROUP, PC
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjogrens syndrome No dispute reported 06/30/2026 1190308640
Principal investigator 1 Janssen Research & Development, LLC $18,280.00 05/05/2025 Non-covered Recipient Entity
NORTH GEORGIA RHEUMATOLOGY GROUP PC
A Multi Center Randomized Double blind Placebo controlled Parallel group Study of Nipocalimab in Adult Participants with Active Systemic Lupus Erythematosus No dispute reported 06/30/2026 1175390587
Principal investigator 1 Novartis Pharmaceuticals Corporation $945.10 03/10/2025 Non-covered Recipient Entity
NORTH GEORGIA RHEUMATOLOGY GROUP, PC
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjogrens syndrome No dispute reported 06/30/2026 1190303005
Principal investigator 1 Janssen Research & Development, LLC $4,940.00 02/10/2025 Non-covered Recipient Entity
NORTH GEORGIA RHEUMATOLOGY GROUP PC
A Multi Center Randomized Double blind Placebo controlled Parallel group Study of Nipocalimab in Adult Participants with Active Systemic Lupus Erythematosus No dispute reported 06/30/2026 1175390581
Principal investigator 1 Novartis Pharmaceuticals Corporation $26,536.00 01/28/2025 Non-covered Recipient Entity
NORTH GEORGIA RHEMATOLOGY GROUP PC
A randomized, double-blind 2-arm NEPTUNUS extension study to assess the long-term safety and efficacy of ianalumab in patients with Sjogrens syndrome No dispute reported 06/30/2026 1190309710
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $52,263.13 01/21/2025 Non-covered Recipient Entity
North Georgia Rheumatology Group, PC
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1) No dispute reported 06/30/2026 1235995297
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $21,465.19 01/06/2025 Non-covered Recipient Entity
North Georgia Rheumatology Group, PC
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) No dispute reported 06/30/2026 1235995295